Shiv Joshi
Department of Community Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences (Demmed to be University), Sawangi (Meghe), Wardha, Maharashtra, IndiaPublications
-
Review Article
USE OF TOCILIZUMAB IN COVID-19 INFECTION
Author(s): Pranjal Toshniwal and Shiv Joshi*
Background: Cytokine storm is one of the severe clinical outcome of COVID-19 which is indicate the patient’s critical condition. The progression of cytokine storm is extremely fast and needs to be control any how in order to prevent the patients from meeting with fatal clinical outcome. Summary: The novel Coronavirus created so much havoc because of two reasons. First the high transmissibility of the novel Coronavirus makes it extremely difficult to contain in certain geographical extent. Second is its capacity to create unmanageable medical complications which can give rise to fatality figures. Repurposing of drugs to treat the patients of COVID-19 was inevitable as no course of treatment or medications were viable. Till date no definite treatment is available for COVID-19 and ad hoc administration of drugs according to the condition .. Read More»